Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market report explains the definition, types, applications, major countries, and major players of the Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Hospira
Mylan
Pfizer
Dr Reddy's Laboratories
Aurobindo Pharma
Novartis
Zhejiang NHU
Boehringer Ingelheim
Teva Pharmaceutical
Lonza Group
Wuxi Apptec
Actavis
By Type:
Paracetamol
Ibuprofen
Aspirin
Naproxen
Others
By End-User:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Outlook to 2028- Original Forecasts
-
2.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market- Recent Developments
-
6.1 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market News and Developments
-
6.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Deals Landscape
7 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Raw Materials and Cost Structure Analysis
-
7.1 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Key Raw Materials
-
7.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Price Trend of Key Raw Materials
-
7.3 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Key Suppliers of Raw Materials
-
7.4 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Concentration Rate of Raw Materials
-
7.5 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Cost Structure Analysis
-
7.5.1 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Raw Materials Analysis
-
7.5.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Labor Cost Analysis
-
7.5.3 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Manufacturing Expenses Analysis
8 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Import and Export Analysis (Top 10 Countries)
-
8.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Export by Region (Top 10 Countries) (2017-2028)
9 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Outlook by Types and Applications to 2022
-
9.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Paracetamol Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Ibuprofen Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Aspirin Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Naproxen Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Online Pharmacies Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Analysis and Outlook till 2022
-
10.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption (2017-2022)
-
10.2.2 Canada Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption (2017-2022)
-
10.2.3 Mexico Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption (2017-2022)
-
10.3.2 UK Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption (2017-2022)
-
10.3.3 Spain Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption (2017-2022)
-
10.3.4 Belgium Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption (2017-2022)
-
10.3.5 France Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption (2017-2022)
-
10.3.6 Italy Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption (2017-2022)
-
10.3.7 Denmark Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption (2017-2022)
-
10.3.8 Finland Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption (2017-2022)
-
10.3.9 Norway Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption (2017-2022)
-
10.3.10 Sweden Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption (2017-2022)
-
10.3.11 Poland Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption (2017-2022)
-
10.3.12 Russia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption (2017-2022)
-
10.3.13 Turkey Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption (2017-2022)
-
10.4.2 Japan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption (2017-2022)
-
10.4.3 India Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption (2017-2022)
-
10.4.4 South Korea Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption (2017-2022)
-
10.4.5 Pakistan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption (2017-2022)
-
10.4.6 Bangladesh Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption (2017-2022)
-
10.4.7 Indonesia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption (2017-2022)
-
10.4.8 Thailand Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption (2017-2022)
-
10.4.9 Singapore Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption (2017-2022)
-
10.4.10 Malaysia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption (2017-2022)
-
10.4.11 Philippines Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption (2017-2022)
-
10.4.12 Vietnam Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption (2017-2022)
-
10.5.2 Colombia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption (2017-2022)
-
10.5.3 Chile Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption (2017-2022)
-
10.5.4 Argentina Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption (2017-2022)
-
10.5.5 Venezuela Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption (2017-2022)
-
10.5.6 Peru Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption (2017-2022)
-
10.5.7 Puerto Rico Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption (2017-2022)
-
10.5.8 Ecuador Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption (2017-2022)
-
10.6.2 Kuwait Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption (2017-2022)
-
10.6.3 Oman Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption (2017-2022)
-
10.6.4 Qatar Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption (2017-2022)
-
10.6.5 Saudi Arabia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption (2017-2022)
-
10.6.6 United Arab Emirates Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption (2017-2022)
-
10.7.2 South Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption (2017-2022)
-
10.7.3 Egypt Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption (2017-2022)
-
10.7.4 Algeria Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption (2017-2022)
-
10.8.2 New Zealand Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption (2017-2022)
11 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Competitive Analysis
-
11.1 Hospira
-
11.1.1 Hospira Company Details
-
11.1.2 Hospira Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Hospira Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Main Business and Markets Served
-
11.1.4 Hospira Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Mylan
-
11.2.1 Mylan Company Details
-
11.2.2 Mylan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Mylan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Main Business and Markets Served
-
11.2.4 Mylan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Pfizer
-
11.3.1 Pfizer Company Details
-
11.3.2 Pfizer Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Pfizer Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Main Business and Markets Served
-
11.3.4 Pfizer Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Dr Reddy's Laboratories
-
11.4.1 Dr Reddy's Laboratories Company Details
-
11.4.2 Dr Reddy's Laboratories Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Dr Reddy's Laboratories Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Main Business and Markets Served
-
11.4.4 Dr Reddy's Laboratories Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Aurobindo Pharma
-
11.5.1 Aurobindo Pharma Company Details
-
11.5.2 Aurobindo Pharma Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Aurobindo Pharma Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Main Business and Markets Served
-
11.5.4 Aurobindo Pharma Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Novartis
-
11.6.1 Novartis Company Details
-
11.6.2 Novartis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Novartis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Main Business and Markets Served
-
11.6.4 Novartis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Zhejiang NHU
-
11.7.1 Zhejiang NHU Company Details
-
11.7.2 Zhejiang NHU Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Zhejiang NHU Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Main Business and Markets Served
-
11.7.4 Zhejiang NHU Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Boehringer Ingelheim
-
11.8.1 Boehringer Ingelheim Company Details
-
11.8.2 Boehringer Ingelheim Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Boehringer Ingelheim Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Main Business and Markets Served
-
11.8.4 Boehringer Ingelheim Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Teva Pharmaceutical
-
11.9.1 Teva Pharmaceutical Company Details
-
11.9.2 Teva Pharmaceutical Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Teva Pharmaceutical Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Main Business and Markets Served
-
11.9.4 Teva Pharmaceutical Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Lonza Group
-
11.10.1 Lonza Group Company Details
-
11.10.2 Lonza Group Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Lonza Group Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Main Business and Markets Served
-
11.10.4 Lonza Group Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Wuxi Apptec
-
11.11.1 Wuxi Apptec Company Details
-
11.11.2 Wuxi Apptec Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Wuxi Apptec Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Main Business and Markets Served
-
11.11.4 Wuxi Apptec Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Actavis
-
11.12.1 Actavis Company Details
-
11.12.2 Actavis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Actavis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Main Business and Markets Served
-
11.12.4 Actavis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolio
-
11.12.5 Recent Research and Development Strategies
12 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Outlook by Types and Applications to 2028
-
12.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Paracetamol Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Ibuprofen Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Aspirin Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global Naproxen Consumption Forecast and Growth Rate (2022-2028)
-
12.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Analysis and Outlook to 2028
-
13.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast (2022-2028)
-
13.2.2 Canada Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast (2022-2028)
-
13.2.3 Mexico Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast (2022-2028)
-
13.3.2 UK Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast (2022-2028)
-
13.3.3 Spain Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast (2022-2028)
-
13.3.4 Belgium Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast (2022-2028)
-
13.3.5 France Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast (2022-2028)
-
13.3.6 Italy Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast (2022-2028)
-
13.3.7 Denmark Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast (2022-2028)
-
13.3.8 Finland Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast (2022-2028)
-
13.3.9 Norway Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast (2022-2028)
-
13.3.10 Sweden Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast (2022-2028)
-
13.3.11 Poland Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast (2022-2028)
-
13.3.12 Russia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast (2022-2028)
-
13.3.13 Turkey Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast (2022-2028)
-
13.4.2 Japan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast (2022-2028)
-
13.4.3 India Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast (2022-2028)
-
13.4.4 South Korea Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast (2022-2028)
-
13.4.8 Thailand Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast (2022-2028)
-
13.4.9 Singapore Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast (2022-2028)
-
13.4.11 Philippines Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast (2022-2028)
-
13.5.2 Colombia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast (2022-2028)
-
13.5.3 Chile Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast (2022-2028)
-
13.5.4 Argentina Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast (2022-2028)
-
13.5.6 Peru Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast (2022-2028)
-
13.6.3 Oman Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast (2022-2028)
-
13.6.4 Qatar Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast (2022-2028)
-
13.7.2 South Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast (2022-2028)
-
13.7.3 Egypt Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast (2022-2028)
-
13.7.4 Algeria Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
-
Figure of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Picture
-
Table Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Paracetamol Consumption and Growth Rate (2017-2022)
-
Figure Global Ibuprofen Consumption and Growth Rate (2017-2022)
-
Figure Global Aspirin Consumption and Growth Rate (2017-2022)
-
Figure Global Naproxen Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Online Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption by Country (2017-2022)
-
Table North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption by Country (2017-2022)
-
Figure United States Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption and Growth Rate (2017-2022)
-
Figure Canada Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption and Growth Rate (2017-2022)
-
Figure Mexico Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption and Growth Rate (2017-2022)
-
Table Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption by Country (2017-2022)
-
Figure Germany Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption and Growth Rate (2017-2022)
-
Figure UK Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption and Growth Rate (2017-2022)
-
Figure Spain Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption and Growth Rate (2017-2022)
-
Figure Belgium Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption and Growth Rate (2017-2022)
-
Figure France Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption and Growth Rate (2017-2022)
-
Figure Italy Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption and Growth Rate (2017-2022)
-
Figure Denmark Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption and Growth Rate (2017-2022)
-
Figure Finland Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption and Growth Rate (2017-2022)
-
Figure Norway Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption and Growth Rate (2017-2022)
-
Figure Sweden Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption and Growth Rate (2017-2022)
-
Figure Poland Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption and Growth Rate (2017-2022)
-
Figure Russia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption and Growth Rate (2017-2022)
-
Figure Turkey Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption and Growth Rate (2017-2022)
-
Table APAC Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption by Country (2017-2022)
-
Figure China Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption and Growth Rate (2017-2022)
-
Figure Japan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption and Growth Rate (2017-2022)
-
Figure India Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption and Growth Rate (2017-2022)
-
Figure South Korea Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption and Growth Rate (2017-2022)
-
Figure Thailand Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption and Growth Rate (2017-2022)
-
Figure Singapore Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption and Growth Rate (2017-2022)
-
Figure Philippines Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption and Growth Rate (2017-2022)
-
Table South America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption by Country (2017-2022)
-
Figure Brazil Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption and Growth Rate (2017-2022)
-
Figure Colombia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption and Growth Rate (2017-2022)
-
Figure Chile Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption and Growth Rate (2017-2022)
-
Figure Argentina Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption and Growth Rate (2017-2022)
-
Figure Peru Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption and Growth Rate (2017-2022)
-
Table GCC Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption by Country (2017-2022)
-
Figure Bahrain Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption and Growth Rate (2017-2022)
-
Figure Oman Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption and Growth Rate (2017-2022)
-
Figure Qatar Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption and Growth Rate (2017-2022)
-
Table Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption by Country (2017-2022)
-
Figure Nigeria Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption and Growth Rate (2017-2022)
-
Figure South Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption and Growth Rate (2017-2022)
-
Figure Egypt Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption and Growth Rate (2017-2022)
-
Figure Algeria Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption and Growth Rate (2017-2022)
-
Table Oceania Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption by Country (2017-2022)
-
Figure Australia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption and Growth Rate (2017-2022)
-
Table Hospira Company Details
-
Table Hospira Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hospira Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Main Business and Markets Served
-
Table Hospira Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolio
-
Table Mylan Company Details
-
Table Mylan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mylan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Main Business and Markets Served
-
Table Mylan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolio
-
Table Pfizer Company Details
-
Table Pfizer Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Main Business and Markets Served
-
Table Pfizer Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolio
-
Table Dr Reddy's Laboratories Company Details
-
Table Dr Reddy's Laboratories Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dr Reddy's Laboratories Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Main Business and Markets Served
-
Table Dr Reddy's Laboratories Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolio
-
Table Aurobindo Pharma Company Details
-
Table Aurobindo Pharma Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Aurobindo Pharma Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Main Business and Markets Served
-
Table Aurobindo Pharma Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolio
-
Table Novartis Company Details
-
Table Novartis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Main Business and Markets Served
-
Table Novartis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolio
-
Table Zhejiang NHU Company Details
-
Table Zhejiang NHU Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Zhejiang NHU Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Main Business and Markets Served
-
Table Zhejiang NHU Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolio
-
Table Boehringer Ingelheim Company Details
-
Table Boehringer Ingelheim Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Main Business and Markets Served
-
Table Boehringer Ingelheim Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolio
-
Table Teva Pharmaceutical Company Details
-
Table Teva Pharmaceutical Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceutical Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Main Business and Markets Served
-
Table Teva Pharmaceutical Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolio
-
Table Lonza Group Company Details
-
Table Lonza Group Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lonza Group Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Main Business and Markets Served
-
Table Lonza Group Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolio
-
Table Wuxi Apptec Company Details
-
Table Wuxi Apptec Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Wuxi Apptec Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Main Business and Markets Served
-
Table Wuxi Apptec Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolio
-
Table Actavis Company Details
-
Table Actavis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Actavis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Main Business and Markets Served
-
Table Actavis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolio
-
Figure Global Paracetamol Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ibuprofen Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Aspirin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Naproxen Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast by Country (2022-2028)
-
Table North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast by Country (2022-2028)
-
Figure United States Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast by Country (2022-2028)
-
Figure Germany Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast by Country (2022-2028)
-
Figure China Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast by Country (2022-2028)
-
Figure Brazil Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast by Country (2022-2028)
-
Figure Australia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast and Growth Rate (2022-2028)
-
